Status:
COMPLETED
Brief Digital CBT for Mood and Anxiety Symptoms in Acute Psychiatric Inpatients
Lead Sponsor:
Centre for Addiction and Mental Health
Conditions:
Anxiety
Depressive Symptoms
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
A randomized control trial examining the feasibility, acceptability, and preliminary efficacy of providing access to the MindShift CBT mobile app via tablet for acute psychiatric inpatients.
Detailed Description
Psychiatric inpatients expect more psychosocial intervention during their inpatient stay than they receive. During the COVID-19 pandemic, existing interventions have been further reduced. Mood and anx...
Eligibility Criteria
Inclusion
- Admitted to the acute inpatient unit
- Fluent in English
- Dynamic Appraisal for Situational Aggression (DASA) score \<=3
- Capable to consent to participation as assessed by the treating physician
Exclusion
- Diagnosis of moderate-severe learning disability
- Diagnosis of moderate-severe neurocognitive disorder
Key Trial Info
Start Date :
April 12 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 11 2021
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT04841603
Start Date
April 12 2021
End Date
May 11 2021
Last Update
July 27 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre for Addiction and Mental Health
Toronto, Ontario, Canada, M6J1H4